Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseasesResponse to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677-1683.
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Stefano
S
Gentileschi
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Cristiana
C
Barreca
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Francesca
F
Bellisai
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Giovanni
G
Biasi
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Maria Giuseppina
MG
Brizi
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Renato
R
De Stefano
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Marta
M
Fabbroni
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Antonella
A
Fioravanti
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Elena
E
Frati
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Enrico
E
Selvi
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Antonio
A
Vitale
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Luca
L
Cantarini
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Bruno
B
Frediani
a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Mauro
M
Galeazzi
D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals; D006801:Humans; D000069285:Infliximab; D011446:Prospective Studies; D012216:Rheumatic Diseases; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals; C000591237:CT-P13; D000069285:Infliximab